I made yet another shares purchase today and this time round, the company picked was C&O Pharmaceutical Technology Limited [E92.SI].
The main reason why I bought this C&O is due to impressive to-come dividends. As anticipated by Philip Research, 4Q dividend could be at S$0.012 which makes the whole year dividend to be at S$0.08. If we were to use today's S$0.47/share, it would be 17%! This very healthy net cash comes after they sold Hong kong asset, which add to their EPS.
1 past dividend and 1 coming soon
Ex Date: 26 Aug 2010 SGD 0.028
Ex Date: 12 Jul 2010 SGD 0.005
Ex Date: 12 Jul 2010 SGD 0.035
This China-based drug maker's strong R&D capability provides springboard to launch new products, paving way for expansion in local and international markets. According to CIMB analyst, C&O is also an attractive partner to foreign drug companies looking to enter the China market.
Stay invested for the dividends remain my key investment strategy.
Subscribe to:
Post Comments (Atom)
Popular Posts
-
新加坡人口400万，亚洲人口4亿，全世界人口6亿。 但是，我一人可能就很有可能是世界最傻的了。我真是个不折不扣的大木头。真是受不了自己。
-
If you live in the North-East and commute early, your daily transit routine just got a whole lot sweeter. The Land Transport Authority (LTA)...
-
Ever looked up from your phone, realized your bus was pulling away, and had to sprint like you were running the 2.4km NAPFA test? We are put... -
It is indeed very sad news coming from Google - Google Reader is to be discontinued from 1 July 2013 onwards. This is Google's yet anot... -
Google url shortener service, goo.gl , is now much improved with newly included features like easier copy and paste, and ability to delete e...
No comments:
Post a Comment
Do provide your constructive comment. I appreciate that.